Deal Announcements

Combinent Biomedical Adds Venture Capital Equity

Tuesday, October 02, 2012 5:32:00 AM PDT | VentureDeal

   Lexington, Massachusetts  --  Pharmaceutical company Combinent Biomedical Systems has garnered $600,000 in new venture capital investment, according to an SEC regulatory filing.

Combinent is developing drug combinations of existing pharmaceutical products using its transvaginal drug delivery system.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1